Cardiovascular Diseases

255 treatments and conditions followed through the public trial records. Not medical advice. How a status is set

Lists the pairs whose condition is this category or one beneath it. A category is not a diagnosis and not advice.

Narrower: Acute Coronary Syndrome 12, Aneurysm 1, Angina Pectoris 9, Angina, Stable 3, Angina, Unstable 1, Anterior Wall Myocardial Infarction 1, Arrhythmias, Cardiac 10, Arterial Occlusive Diseases 46, Arteriosclerosis 45, Arteriovenous Malformations 1, Atherosclerosis 20, Atrial Fibrillation 7, Cardiomyopathies 8, Cardiomyopathy, Dilated 1, Cardiomyopathy, Hypertrophic 2, Coronary Artery Disease 24, Coronary Disease 28, Coronary Stenosis 1, Ductus Arteriosus, Patent 2, Embolism 1, Essential Hypertension 1, Heart Arrest 3, Heart Defects, Congenital 3, Heart Diseases 170, Heart Failure 40, Heart Failure, Diastolic 1, Heart Failure, Systolic 3, Hyperemia 1, Hypertension 28, Hypertrophy, Left Ventricular 1, Hypotension 1, Intermittent Claudication 2, Klippel-Trenaunay-Weber Syndrome 1, Microvascular Angina 2, Mitral Valve Insufficiency 1, Mitral Valve Prolapse 1, Myocardial Infarction 27, Myocardial Reperfusion Injury 1, Myocarditis 1, Non-ST Elevated Myocardial Infarction 5, Pericarditis 1, Peripheral Arterial Disease 4, Prehypertension 3, Reperfusion Injury 2, Shock, Cardiogenic 1, ST Elevation Myocardial Infarction 10, Tachycardia, Ventricular 1, Telangiectasia, Hereditary Hemorrhagic 2, Thrombosis 3, Tricuspid Valve Insufficiency 22, Vascular Malformations 4, Vasculitis 2, Venous Thromboembolism 3, Ventricular Dysfunction, Right 2, Ventricular Fibrillation 1

Treatments and conditions

Cardiovascular Diseases
Treatment and conditionWhere it standsTrials
"Trained Eye" (Angiography-Guided) LM PCI for coronary artery diseaseTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
1 Stent for coronary artery diseaseTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
2 Stents for coronary artery diseaseTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Acetylcysteine for st elevation myocardial infarctionTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Amiodarone for heart arrestPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Amrecibart for atrial fibrillationPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)2
Amrecibart for thrombosisPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)2
Amrecibart for venous thromboembolismPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Apixaban for heart failurePhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Apixaban for thrombosisPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Arm 1: treatment with Shockwave Reducer for angina pectorisTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Aroxxen for coronary artery diseasePhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Atorvastatin for myocardial infarctionTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Autoinjector + EVOLOCUMAB for coronary artery diseaseTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Avacopan for vasculitisTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Baxdrostat for hypertensionPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)3
BiOSS LIM C for coronary artery diseaseTrials ended early, as of 19 Nov 2026 (not yet checked by a person)1
BiOSS LIM C for coronary stenosisTrials ended early, as of 19 Nov 2026 (not yet checked by a person)1
BiVACOR TAH System for heart failureTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Bread with added beta-glucans for hypertensionTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
CagriSema for hypertensionTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Calf Plantar flexion + Dietary nitrate for peripheral arterial diseasePhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Canakinumab for atherosclerosisPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Canakinumab for myocardial infarctionPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Cardiovalve TR valve replacement System for tricuspid valve insufficiencyTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Cardiovascular Polypill for myocardial infarctionPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Cardiovascular Polypill (Valsartan, Atorvastatin, Aspirin) + Colchicine 0.5 mg for atherosclerosisPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Cardiovascular Polypill (Valsartan, Atorvastatin, Aspirin) + Colchicine-placebo 0.5 mg for atherosclerosisPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Carvedilol for heart failurePhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1
Cenvacibart for atrial fibrillationPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)2
Cenvacibart for thrombosisPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)2
Cenvacibart for venous thromboembolismPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Cholecalciferol for myocardial infarctionPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Clazakizumab for atherosclerosisPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Clazakizumab for hypertensionPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Clopidogrel for acute coronary syndromeTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Clopidogrel for angina, stableTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Clopidogrel for myocardial infarctionTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Colchicine for acute coronary syndromePhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Colchicine for coronary artery diseasePhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Colchicine for coronary diseasePhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Colchicine for heart failurePhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Colchicine for myocardial infarctionPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Colchicine for myocarditisPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Colchicine 0.5 mg for atherosclerosisTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Colchicine 0.5 mg for coronary diseasePhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Colchicine 0.5 mg for heart diseasesPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Colchicine 0.5 mg + Usual Care Group for atherosclerosisPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Colchicine-placebo 0.5 mg + Usual Care Group for atherosclerosisPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Combined antioxidant therapy for myocardial reperfusion injuryTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Combined antioxidant therapy for st elevation myocardial infarctionTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Control for hypertensionTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Coronary Sinus Reducer for angina pectorisTrial registered, as of 19 Nov 2026 (not yet checked by a person)2
Coronary Sinus Reducer for angina, stableTrial registered, as of 19 Nov 2026 (not yet checked by a person)2
Coronary Sinus Reducer for coronary artery diseaseTrial registered, as of 19 Nov 2026 (not yet checked by a person)2
Coronary Sinus Reducer for microvascular anginaTrial registered, as of 19 Nov 2026 (not yet checked by a person)2
Dapagliflozin for heart failureTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Dapagliflozin + Empagliflozin for heart failure, systolicTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Dapagliflozin propanediol for heart failure, systolicTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
DCD Heart Transplantation Using NRP for heart failureTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
DIAG723 for telangiectasia, hereditary hemorrhagicPhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1
Direct oral anticoagulant for acute coronary syndromePhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Direct oral anticoagulant for embolismPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Direct oral anticoagulant for heart failurePhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Direct oral anticoagulant for st elevation myocardial infarctionPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
EA-230 90mg/kg/hour for coronary artery diseasePhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Echocardiography + Electrocardiogram (ECG) + DEFERIPRONE + Deferoxamine + Deferasirox for arrhythmias, cardiacPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Echocardiography + Electrocardiogram (ECG) + DEFERIPRONE + Deferoxamine + Deferasirox for cardiomyopathiesPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
EDG-15400 25 mg for heart failurePhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
EDG-15400 50 mg for heart failurePhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Edwards EVOQUE System for heart failureTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Edwards EVOQUE System for tricuspid valve insufficiencyTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Edwards EWJ-202 Transcatheter Tricuspid Valve Replacement System for tricuspid valve insufficiencyTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Electronic Cigarette and behavioural change support. for cardiovascular diseasesTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Eloralintide for cardiovascular diseasesTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Empagliflozin for cardiomyopathy, hypertrophicPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Empagliflozin for heart defects, congenitalPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)2
Empagliflozin for heart failurePhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)13
Empagliflozin for heart failure, diastolicPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Empagliflozin for ventricular dysfunction, rightPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Enavogliflozin for tricuspid valve insufficiencyPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Endocalyx Pro for hypertensionPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
ENDS (Vaporizer/e-cig) and smoking cessation counseling for cardiovascular diseasesTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Enlicitide Decanoate for arteriosclerosisPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Essential Pro Paclitaxel Drug-Eluting Balloon for coronary artery diseaseTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Evolocumab for coronary artery diseasePhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)2
Evolocumab for coronary diseasePhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Evolocumab for non-st elevated myocardial infarctionPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Evolocumab for st elevation myocardial infarctionPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Exercise for hypertensionTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Exploratory test group for hypertensionPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Ferric derisomaltose for heart failurePhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Finerenone for atrial fibrillationPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Fisetin for intermittent claudicationPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Fixed-Dose Combination Strategy for hypertensionTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Flecainide for heart arrestPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Flecainide for mitral valve prolapsePhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Food Security Screening & Referral Program for cardiovascular diseasesPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Genicular artery embolization (GAE) for arterial occlusive diseasesTrials ended early, as of 19 Nov 2026 (not yet checked by a person)1
Goflikicept for pericarditisPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Heart to Heart Yoga for heart failureTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
HiCM-188 therapy for heart failureTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
High dose CABG/LVAD+iPSC-CMs for heart failureTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
High dose Jia Shen Tablet for heart failureTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
High Dose LX2006 + Low dose LX2006 + Mid Dose LX2006 for cardiomyopathiesPhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1
High-resistance inspiratory muscle strength training for hypertensionTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
hiPSC-CM therapy for cardiomyopathy, dilatedPhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1
hiPSC-CM therapy for heart failurePhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)2
Hyperpolarized 13C-pyruvate for heart failurePhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
IBI3016 for hypertensionPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Ibuprofen for ductus arteriosus, patentPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
iCM012 solution 2 mg/mL for reperfusion injuryTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Ime for hypertensionTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Ime for prehypertensionTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Impella 5.5 for shock, cardiogenicTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Inclisiran for acute coronary syndromePhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Inclisiran for non-st elevated myocardial infarctionPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Inclisiran for st elevation myocardial infarctionPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Infliximab for aneurysmPhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1
Infliximab for vasculitisPhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1
Innoventric Unica™ System for tricuspid valve insufficiencyTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Inspiratory muscle strength training for hypertensionTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Inspiratory muscle strength training for prehypertensionTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Inspiratory muscle training (IMT) for hypertensionTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Intensified medical follow-up and glucose-lowering drugs for coronary artery diseaseTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Intrepid™ TTVR System for tricuspid valve insufficiencyTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
L-PSGB first for tachycardia, ventricularTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
L-PSGB first for ventricular fibrillationTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Laplace TTVR System for tricuspid valve insufficiencyTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Left main stenting with intravascular lithotripsy for atherosclerosisTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Left main stenting with intravascular lithotripsy for coronary artery diseaseTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Lepodisiran for atherosclerosisPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Lepodisiran Sodium for atherosclerosisPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Lorundrostat for hypertensionPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)3
Lorundrostat 25mg+SGLT2i QD, Washout, Placebo+SGLT2i QD for hypertensionPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
low dose CABG+iPSC-CMs for heart failureTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Low dose Jia Shen Tablet for heart failureTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
LuxValve PLlus for tricuspid valve insufficiencyTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Mandibular advancement Device for essential hypertensionTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Mandibular advancement Device for heart failureTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Mandibular advancement Device for hypertensionTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Maridebart Cafraglutide for atherosclerosisPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Medical or interventional therapy for rhythm control in atrial fibrillation (antiarrhythmic drugs, ablation, electric cardio version) for atrial fibrillationPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Medtronic Intrepid™ Transcatheter Tricuspid Valve Replacement (TTVR) System for tricuspid valve insufficiencyTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Metformin ER for intermittent claudicationPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Metformin hydrochloride for heart failurePhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1
Midodrine for hypotensionPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
MitraClip System for heart failureTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
MitraClip System for mitral valve insufficiencyTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Muvalaplin for atherosclerosisPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Narrative Intervention for Chronic Illness-Heart Failure for heart failureTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Neovasc Reducer for angina pectorisTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Nevibolol for microvascular anginaTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Nicotine-Free Electronic Cigarette and behavioural change support. for cardiovascular diseasesTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
NightWare for cardiovascular diseasesTrial registered, as of 19 Nov 2026 (not yet checked by a person)2
Nintedanib for telangiectasia, hereditary hemorrhagicPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
NTLA-2001 for cardiomyopathiesPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)2
obicetrapib 10 mg + ezetimibe 10 mg FDC daily for coronary artery diseasePhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Orforglipron for cardiovascular diseasesPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Orforglipron for hypertensionPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)2
Pci for acute coronary syndromeTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
pharmacogenetic algorithm for atrial fibrillationPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Placebo + Empagliflozin for heart failurePhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)2
Placebo + Lorundrostat for hypertensionPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)2
Placebo + Orforglipron for hypertensionPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Placebo QD + SGLT2i QD, Washout, Lorundrostat 25mg+SGLT2i QD for hypertensionPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Polycap for atherosclerosisPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
PolyCore (Polydextrin, L-Carnitine, D-xylitol) for heart failurePhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1
PolyPill for cardiovascular diseasesPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)2
PolyPill for heart diseasesTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
PolyPill for hypertensionTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
PolyPill for non-st elevated myocardial infarctionPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
PolyPill for st elevation myocardial infarctionPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Polypill: Red Heart Pill for cardiovascular diseasesTrials ended early, as of 19 Nov 2026 (not yet checked by a person)1
Prasugrel for acute coronary syndromeTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Prasugrel or Ticagrelor for acute coronary syndromePhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Prasugrel or Ticagrelor for atrial fibrillationPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Qidan Xiaoke Granules + Standard Medical Therapy for coronary artery diseaseTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Ranolazine for heart failurePhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Ranolazine for ventricular dysfunction, rightPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Recombinant Human Thymosin Beta 4 Injection (NL005) for anterior wall myocardial infarctionTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Recombinant Human Thymosin Beta 4 Injection (NL005) for st elevation myocardial infarctionTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Recombinant varicella zoster virus glycoprotein e antigen for cardiovascular diseasesTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Recombinant varicella zoster virus glycoprotein e antigen for myocardial infarctionPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Red Heart Pill 2b (Polypill) for cardiovascular diseasesTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Regadenoson for coronary artery diseasePhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1
Retatrutide for cardiovascular diseasesPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Retatrutide for coronary artery diseasePhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Retatrutide for peripheral arterial diseasePhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Rivaroxaban for venous thromboembolismPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
RP-A501 for cardiomyopathy, hypertrophicPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)2
RP-A501 for hypertrophy, left ventricularPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Sacubitril-valsartan for heart failurePhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1
SAL0140 for hypertensionPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Selnoflast for atherosclerosisPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Semaglutide for atherosclerosisPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Semaglutide for atrial fibrillationPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Silver diammine fluoride for heart arrestTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Sirolimus for arteriovenous malformationsPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Sodium zirconium cyclosilicate for heart failurePhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)2
Tai Chi (CHI) for hypertensionTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Tai Chi (CHI) for prehypertensionTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Tenecteplase for st elevation myocardial infarctionPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Tertinat for atherosclerosisPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Tertinat for coronary artery diseasePhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Test group for hypertensionPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Thiamine Mononitrate 300 mg for heart failurePhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Ticagrelor for acute coronary syndromePhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)19
Ticagrelor for angina, stableTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Ticagrelor for angina, unstablePhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)2
Ticagrelor for coronary artery diseasePhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)7
Ticagrelor for myocardial infarctionPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Ticagrelor for non-st elevated myocardial infarctionPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Ticagrelor for st elevation myocardial infarctionPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)2
Ticagrelor + Aspirin for acute coronary syndromeTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Ticagrelor + placebo for non-st elevated myocardial infarctionPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Ticagrelor + placebo for st elevation myocardial infarctionPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Tirzepatide for heart failure, systolicTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Tirzepatide for hypertensionTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
TNX-103 for heart failurePhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Topaz TTVR System for tricuspid valve insufficiencyTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Transcatheter PDA Coil for ductus arteriosus, patentTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Transcatheter tricuspid valve edge-to-edge repair for heart failureTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Transcatheter tricuspid valve edge-to-edge repair for tricuspid valve insufficiencyTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Transcatheter Tricuspid Valve Intervention for tricuspid valve insufficiencyTrial registered, as of 19 Nov 2026 (not yet checked by a person)2
Transcatheter tricuspid valve replacement for tricuspid valve insufficiencyTrial registered, as of 19 Nov 2026 (not yet checked by a person)6
Transcatheter Tricuspid Valve Replacement (TTVR) with Laplace TTVR System for tricuspid valve insufficiencyTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Transcatheter Tricuspid Valve Replacement (TTVR) with VDyne TriNova System for tricuspid valve insufficiencyTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Transcatheter Tricuspid Valved Stent Graft for tricuspid valve insufficiencyTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Transvenous Tricuspid Valve System implantation + OMT for tricuspid valve insufficiencyTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
TRiCares Topaz TTVR System for tricuspid valve insufficiencyTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Tricuspid Valve Replacement System for tricuspid valve insufficiencyTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Tricuspid Valve Replacement System via jugular vein for tricuspid valve insufficiencyTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
TricValve System for heart failureTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
trigagrelor for acute coronary syndromeTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Triple oral lipid lowering treatment for acute coronary syndromeTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
TruGamma System for tricuspid valve insufficiencyTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Valsartan for heart failurePhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1
VDyne Transcatheter Tricuspid Valve Replacement System for tricuspid valve insufficiencyTrial registered, as of 19 Nov 2026 (not yet checked by a person)2
Venous Excess Ultrasound (VEXUS)-Guided Management for hyperemiaTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Vericiguat for heart failurePhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
VERVE-102 for atherosclerosisPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
VERVE-102 for coronary artery diseasePhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)2
VERVE-102 for myocardial infarctionPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Very-short DAPT less than 1 month after PCI for acute coronary syndromeTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Very-short DAPT less than 1 month after PCI for coronary artery diseaseTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Vicadrostat for hypertensionPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
vicadrostat / empagliflozin combination 1 for heart failurePhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
YMI024 for coronary artery diseasePhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Ziltivekimab for atherosclerosisPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)2
Ziltivekimab for coronary artery diseasePhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Ziltivekimab for myocardial infarctionPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Zotarolimus-eluting stent (Endeavor Resolute) for coronary artery diseaseTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Zovegalisib for klippel-trenaunay-weber syndromePhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Zovegalisib for vascular malformationsPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1

Categories are from Medical Subject Headings (MeSH), U.S. National Library of Medicine, courtesy of the U.S. National Library of Medicine: MeSH. They may not reflect the most current data available from NLM. NLM does not endorse this site.